ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 62 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $138,000 | -35.8% | 36,068 | +1.1% | 0.00% | – |
| Q4 2019 | $215,000 | -20.4% | 35,661 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $270,000 | -37.8% | 35,661 | +11.4% | 0.00% | 0.0% |
| Q2 2019 | $434,000 | +176.4% | 32,011 | +77.5% | 0.00% | – |
| Q1 2018 | $157,000 | -31.7% | 18,035 | -1.9% | 0.00% | – |
| Q4 2017 | $230,000 | +42.9% | 18,388 | -4.7% | 0.00% | – |
| Q3 2017 | $161,000 | -53.1% | 19,300 | -4.5% | 0.00% | -100.0% |
| Q2 2017 | $343,000 | +383.1% | 20,200 | +168.3% | 0.00% | – |
| Q1 2016 | $71,000 | +10.9% | 7,528 | +17.6% | 0.00% | – |
| Q4 2015 | $64,000 | -28.9% | 6,400 | +1.6% | 0.00% | – |
| Q3 2015 | $90,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |